SIGA — SIGA TECHNOLOGIES INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1010086 ·
Last close
$2.73
Market Cap
$196.16M
52W High
$6.29
52W Low
$2.66
ADV30
534,763
Next earnings
2026-11-09
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,316,965 741,305 -6,520,048 -2,893,064 172,648,103 116,380,386 9,394,256
Jun 2026 41,002,253 23,441,068 13,905,578 12,463,434 175,736,786 117,584,444 10,446,151
Mar 2026 6,242,580 3,301,696 -5,321,164 -3,454,252 219,387,858 145,562,142 67,766,256
Dec 2025 3,794,084 804,474 -9,499,735 -5,429,918 219,467,434 154,966,414 20,645,862

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,532,546
Investing CF
$-40,539
Financing CF
$-44,002,113
CapEx
$-355,009
Dividends Paid
$-43,403,472
Buybacks
—
EPS Diluted TTM
$-0.01
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-80,862,568
Inventory
$41,594,073
Receivables
$2,016,213
ST Investments
—
EBIT TTM
$-7,435,369
Pretax Income TTM
$-2,637,638
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$52,355,880
EBITDA
$-6,831,889
Free Cash Flow
$-11,653,347
Enterprise Value
$80,776,960
Total Cash
$116,380,384
Total Debt
$274,605
Shares Out
71,855,015
Trailing EPS
$0.01
Book Value
$2.27
ROE
0.4%
ROA
-2.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 94,574,902 23,702,156 23,279,143 219,467,434 20,645,862 198,821,572 43,471,453
Dec 2024 138,719,350 69,983,274 59,214,216 244,337,026 28,532,263 215,804,763 48,761,807
Dec 2023 139,917,220 83,621,165 68,068,826 254,352,855 57,493,948 196,858,907 94,799,331
Dec 2022 110,775,610 42,700,166 33,904,806 195,035,923 24,875,881 170,160,042 41,611,062
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$53,658,916
NetIncome TTM
$-2,786,555
OpCashFlow TTM
—
Assets (Latest)
$175,736,786
Forward EPS
$1.06

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $3.00 · spot: $2.80 · call volume: 288 · put volume: 10
Expected Move to 2027-03-19: ±$1.17 (41.79%) — implied range $1.63 – $3.97 · ATM straddle on $3.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TRDA Entrada Therapeutics, Inc. $194.19M $4.96 —
VOGX Vogenx, Inc. $200.25M $13.48 —
DRUG BRIGHT MINDS BIOSCIENCES INC. $201.25M $20.51 —
ADCT ADC Therapeutics SA $189.89M $1.35 —
CYPH CYPHERPUNK TECHNOLOGIES INC. $205.29M $1.90 —

News headlines (Yahoo Finance, 1h cache)

SIGA Technologies Inc (SIGA) (Q3 2026) Earnings Call Highlights: New Canada Contract, $116 ...
2026-11-10 07:08 · Yahoo
What Siga Technologies (SIGA) Said on Its Q3 Earnings Call
2026-11-10 03:14 · Yahoo
SIGA Technologies, Inc. Q3 2026 Earnings Call Summary
2026-11-10 02:26 · Yahoo
SIGA (SIGA) Q3 2026 Earnings Call Transcript
2026-11-10 01:01 · Yahoo
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
2026-11-09 21:01 · Yahoo
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
2026-11-09 21:01 · Yahoo
SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results
2026-10-29 11:30 · Yahoo
SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®
2026-10-28 11:30 · Yahoo
SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain
2026-09-06 12:41 · Yahoo
Siga Technologies Q2 Earnings Call Highlights
2026-08-07 12:03 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.